These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Transient receptor potential vanilloid receptor-1 does not contribute to slowly adapting airway receptor activation by inhaled ammonia. Wu M; Qin C; Foreman RD; Farber JP Auton Neurosci; 2007 May; 133(2):121-7. PubMed ID: 17169618 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Wong GY; Gavva NR Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372 [TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding. Lee J; Kim SY; Park S; Lim JO; Kim JM; Kang M; Lee J; Kang SU; Choi HK; Jin MK; Welter JD; Szabo T; Tran R; Pearce LV; Toth A; Blumberg PM Bioorg Med Chem; 2004 Mar; 12(5):1055-69. PubMed ID: 14980619 [TBL] [Abstract][Full Text] [Related]
30. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity. Liu HT; Kuo HC BJU Int; 2007 Nov; 100(5):1086-90. PubMed ID: 17711510 [TBL] [Abstract][Full Text] [Related]
31. The deorphanization of TRPV1 and the emergence of octadecadienoids as a new class of lipid transmitters. Flores CM; Vasko MR Mol Interv; 2010 Jun; 10(3):137-40. PubMed ID: 20539032 [No Abstract] [Full Text] [Related]
32. TRPV1 is involved in stretch-evoked contractile changes in the rat autonomous bladder model: a study with piperine, a new TRPV1 agonist. Gevaert T; Vandepitte J; Hutchings G; Vriens J; Nilius B; De Ridder D Neurourol Urodyn; 2007; 26(3):440-50; discussion 451-3. PubMed ID: 17266134 [TBL] [Abstract][Full Text] [Related]